Rethinking Hospital-Pharma Collaborations for Scaling Digital Health

Digital health is rapidly evolving, prompting a need to reassess how hospitals and pharmaceutical companies collaborate to leverage technology and improve patient care. Traditional partnerships often focused on clinical trials or drug development, but the rise of digital health solutions opens new avenues for cooperation. Hospitals can provide valuable real-world data and insights into patient needs, while pharma companies bring expertise in research, development, and scaling innovations.

However, such partnerships face challenges, including data privacy concerns, regulatory hurdles, and the need to align different organizational cultures and goals. Rethinking these collaborations requires a shift towards more integrated, long-term partnerships that prioritize patient-centric innovation and value-based care models.

Join us to discuss

• What are the main barriers to effective collaboration between hospitals and pharmaceutical companies in digital health initiatives?

• How can the success of digital health collaborations be measured effectively?

• How can these collaborations ensure that patient needs remain at the center of innovation efforts?